1 To investigate the underlying mechanisms,
we undertook (
1) bioinformatic, functional genomic annot
2 We undertook 4 phases of formative research, comprising
3 Here
we undertake a complete thermodynamic characterization o
4 We undertake a data-driven search for a unified physical
5 Here,
we undertake a detailed theoretical and numerical study
6 Here
we undertake a direct high-speed atomic force microscopy
7 Here,
we undertake a first step in this direction by focussing
8 We undertake a large-scale characterization of sex diffe
9 We undertook a 12-month prospective observational cohort
10 To test this hypothesis,
we undertook a 15-mo-long longitudinal entomological sur
11 We undertook a 2-center audit of coding accuracy across
12 We undertook a 2-year national surveillance study (the U
13 Between July 1, and Sept 30, 2013,
we undertook a baseline survey of a population-based, mu
14 We undertook a birth cohort study with not only intensiv
15 We undertook a case-control study with Giardia genotypin
16 We undertook a cluster-randomised controlled trial in So
17 ify direct and indirect EBF1 targets in fat,
we undertook a combination of transcriptional profiling
18 conflicting issues surrounding this biology,
we undertook a comparative analysis of the effects of ne
19 To gain insight into this issue,
we undertook a comparative analysis of the eight major h
20 Consequently,
we undertook a comparative study of metabolites in our t
21 specialized 3' end deep sequencing methods,
we undertook a comprehensive analysis of APA following i
22 ays a significant role in glioma malignancy,
we undertook a comprehensive analysis of sphingolipid me
23 Here,
we undertook a comprehensive analysis of the remaining m
24 nderstand the evolution of these structures,
we undertook a comprehensive assessment of their occurre
25 We undertook a comprehensive clinical and biological inv
26 Here,
we undertook a comprehensive effort to define mechanisms
27 We undertook a comprehensive immunophenotyping approach,
28 We undertook a comprehensive meta-analysis to quantify b
29 We undertook a comprehensive retrospective study of 162
30 We undertook a comprehensive review of community empower
31 We undertook a comprehensive review of the published lit
32 ition in different regions of the same mRNA,
we undertook a comprehensive search for phylogenetically
33 We undertook a comprehensive, systematic assessment of r
34 We undertook a critical review of the effect of moderate
35 We undertook a cross-sectional study of elderly inhabita
36 We undertook a cross-sectional study with 3 phases.
37 We undertook a data-driven time-series analysis to exami
38 ed siblings, and unrelated control children,
we undertook a detailed analysis of proliferation, activ
39 We undertook a detailed dermatological assessment, syphi
40 Here
we undertook a detailed examination of both Xenopus and
41 We undertook a detailed kinetic analysis of the drug res
42 We undertook a detailed neurophysiological investigation
43 Therefore,
we undertook a detailed study of this proteinase and its
44 Here
we undertook a direct test of this mechanism by combinin
45 METHODS AND
We undertook a double-blind randomised controlled trial
46 We undertook a double-blind study using stereological ce
47 We undertook a double-blind, controlled trial between Ja
48 We undertook a double-blind, placebo-controlled, crossov
49 We undertook a double-blind, randomised factorial study
50 We undertook a double-blind, randomised, controlled tria
51 We undertook a draft de novo genome assembly of horsewee
52 Guided by these imaging findings,
we undertook a focused postmortem investigation with ste
53 To identify novel vulnerabilities in MM,
we undertook a focused RNAi screen in which components o
54 We undertook a genome-wide analysis of methylation at Cp
55 We undertook a genome-wide association analysis using 54
56 We undertook a genome-wide association study (GWAS) in 1
57 genetic variation and biology underlying AF,
we undertook a genome-wide association study (GWAS) of 6
58 To identify resistance loci for bTB,
we undertook a genome-wide association study in female H
59 We undertook a genome-wide RNAi screen as an unbiased ap
60 igate the causes for brown and orange morphs
we undertook a genomics approach on corals collected at
61 Next,
we undertook a genotype-phenotype analysis of a large co
62 We undertook a global and systematic approach to build a
63 International Mouse Phenotyping Consortium,
we undertook a hearing loss screen in a cohort of 3006 m
64 ress the paucity of effective new therapies,
we undertook a high-throughput screen to discover small
65 We undertook a histology-independent phase 2 "basket" st
66 We undertook a life-cycle analysis of eight bioproducts
67 We undertook a longitudinal prospective study of 33 indi
68 We undertook a Mendelian randomization (MR) study to eva
69 We undertook a Mendelian randomization study to determin
70 We undertook a Mendelian randomization study using data
71 We undertook a meta-analysis of genome-wide association
72 We undertook a meta-analysis of genome-wide association
73 METHODS AND
We undertook a mixed methods investigation of reports of
74 We undertook a mixed treatment comparison to examine the
75 We undertook a mixed-methods, situational analysis.
76 We undertook a multicenter, randomized, controlled trial
77 We undertook a multicentre, randomised trial on health a
78 We undertook a multifactorial analysis using the Cox pro
79 larify the nitric oxide reductase mechanism,
we undertook a multispectroscopic presteady-state invest
80 We undertook a narrative synthesis of the data in each r
81 We undertook a nationwide follow-up study of a cohort of
82 rther explore genetic association with TGCT,
we undertook a pathway-based analysis of SNP marker asso
83 We undertook a phase 1/2 open-label trial with 12-month
84 We undertook a phase 1b study in patients with advanced
85 We undertook a phase 3 study to assess the efficacy and
86 We undertook a phase 3, randomised, double-blind, placeb
87 We undertook a phase I double-blind, randomized placebo
88 Here,
we undertook a phase I/II pilot study of DES using a nov
89 (EGFR) contributes to radiation resistance,
we undertook a phase II trial of the EGFR inhibitor erlo
90 Sunday June 15 and Wednesday June 18, 2014,
we undertook a point prevalence survey of hospital speci
91 To resolve this
we undertook a population receptive field (pRF) function
92 We undertook a population-based analysis of the Swedish
93 We undertook a population-based cohort analysis, obtaini
94 essive symptoms and early-morning cortisol),
we undertook a population-based investigation to ascerta
95 We undertook a post hoc analysis of 2 randomized clinica
96 We undertook a post-hoc analysis of data from the ROCKET
97 We undertook a pragmatic, multicentre, cluster randomise
98 We undertook a probabilistic sensitivity analysis using
99 We undertook a probability sample survey (the third Nati
100 We undertook a prospective evaluation of UDCA withdrawal
101 We undertook a prospective randomized controlled trial t
102 We undertook a prospective study in rural Kenya.
103 From the United Kingdom TTP registry,
we undertook a prospective study investigating the impac
104 activity of lactadherin sourced by equines,
we undertook a proteomic analysis of milk fat globule me
105 To begin to address this
we undertook a proteomic analysis of three accumulation
106 een previously identified and characterized,
we undertook a proteomic screen to identify additional t
107 We undertook a qualitative study of staff caring for old
108 We undertook a quality improvement initiative with respe
109 We undertook a quantitative proteomic comparison of cell
110 We undertook a randomised, double-blind, phase 1, dose-e
111 ety of primaquine regimens for radical cure,
we undertook a randomized controlled trial in Ethiopia.
112 We undertook a re-analysis of the Canadian data from the
113 In a clinical cohort study,
we undertook a retrospective analysis of clinical survey
114 We undertook a review of the literature to outline the c
115 We undertook a scaffold-hopping approach, entailing the
116 Nine years later,
we undertook a second survey of the same area.
117 In this study,
we undertook a sequential characterization of NK respons
118 ide a structural basis for this observation,
we undertook a series of crystallographic and NMR dynami
119 To test this,
we undertook a series of experiments to shed light on th
120 attempt to better understand these problems,
we undertook a series of ground-based lidar measurements
121 We undertook a series of metabolite analyses of tomatoes
122 and the etiology of the behavioral deficits,
we undertook a series of molecular studies in the dorsal
123 We undertook a single-center review of spinal injured ad
124 We undertook a study in healthy subjects, using the indu
125 We undertook a study to assess the vasodilatory capacity
126 eS cluster attachment in [NiFe] hydrogenase,
we undertook a study to substitute all 12 amino acid pos
127 In the present study,
we undertook a systematic analysis on the expression and
128 th the most neonatal deaths (55% worldwide),
we undertook a systematic assessment of bottlenecks to e
129 We undertook a systematic comparison of eTregs and iTreg
130 We undertook a systematic review and meta-analysis of ra
131 We undertook a systematic review and meta-analysis to co
132 We undertook a systematic review and meta-analysis, usin
133 We undertook a systematic review investigating risks of
134 We undertook a systematic review of peer-reviewed litera
135 We undertook a systematic review of primary research bas
136 We undertook a systematic review of the literature repor
137 We undertook a systematic review of the PubMed, EMBASE,
138 We undertook a systematic review of women's access to an
139 We undertook a systematic review to assess SIT efficacy
140 We undertook a systematic review to assess the safety an
141 We undertook a systematic review to determine how POMR i
142 We undertook a systematic review, which involved searchi
143 We undertook a systematic study of the effects of dietar
144 x cellular dynamics underlying this process,
we undertook a systematic, detailed analysis of pea (Pis
145 To gain insight into this
we undertook a systems biology approach, aiming to gener
146 We undertook a thematic analysis of the collected data,
147 We undertook a time-series analysis of data from the Hea
148 We undertook a total population cohort study in Sweden o
149 lar mechanisms underpinning this phenomenon,
we undertook a transcriptional screen of salt stressed A
150 overall response to Marburg virus challenge,
we undertook a transcriptomic analysis of immune cells c
151 We undertook a transcriptomic characterization of primar
152 on is thought to contribute to AD pathology,
we undertook a triple-tracer small-animal PET study to a
153 Here,
we undertook a unique approach by deriving fibroblast su
154 We undertook a year-long study of benthic (macroinverteb
155 We undertook aggressive supportive measures of hydration
156 Here
we undertake an analysis for quantitative traits utilizi
157 Here
we undertake an expansive phylogenetic analysis of swIAV
158 amino acid composition of a socket and knob,
we undertake an investigation of the knob-socket constru
159 In this work
we undertake an investigation of time scale invariance o
160 Here,
we undertake an unbiased, total genome screen for RNA tr
161 We undertook an analysis of discarded kidneys to determi
162 We undertook an analysis of laboratory-confirmed cases a
163 We undertook an analysis of mitochondrial haplogroups in
164 ion by this post-translational modification,
we undertook an analysis of the X. laevis phosphoproteom
165 We undertook an economic modelling study from the patien
166 Therefore,
we undertook an examination of the thermodynamic propert
167 We undertook an exploratory analysis of change in visual
168 d its lack of effective therapeutic targets,
we undertook an extensive analysis of human RCC tissue e
169 We undertook an extensive analysis of the PDAC transcrip
170 We undertook an extensive computational analysis using a
171 To address this,
we undertook an extensive survey of multiple vegetation
172 We undertook an ICU-wide structured quality improvement
173 istant to SIV infection than RM macrophages,
we undertook an in vitro comparative assessment of monoc
174 mine the stoichiometry of the Nup62 complex,
we undertook an in vitro study using gel filtration and
175 lar activity and their evolutionary history,
we undertook an in-depth analysis of Vasohibin sequences
176 Here
we undertook an in-depth bioinformatical analysis of sep
177 Here
we undertook an in-depth study of alkylphenol-based anes
178 To address this,
we undertook an individual patient data meta-analysis of
179 We undertook an integrated genetic approach to discover
180 lecular features associated with EMT states,
we undertook an integrative approach combining mRNA, miR
181 Here,
we undertook an integrative phenotypic, molecular, and g
182 ials, and correlate genotype with phenotype,
we undertook an international, prospective, cross-sectio
183 igate the relationship between i6A and FPPS,
we undertook an inverse virtual screening computational
184 We undertook an open-label randomised controlled trial a
185 We undertook an open-label, dose-finding, standard 3+3 d
186 We undertook an open-label, international, multicentre,
187 We undertook an open-label, parallel-group, randomised,
188 Therefore,
we undertook an unbiased analysis to identify RNA biomar
189 We undertook an untargeted metabolomics approach to disc
190 essive inheritance pattern of this syndrome,
we undertook autozygosity mapping and whole-exome sequen
191 To further characterize these interactions,
we undertook biochemical and biophysical studies using n
192 We undertook characterization of the prevalence of Pneum
193 e mutations in high-risk neuroblastoma (NB),
we undertook chromatin-focused small interfering RNA and
194 We undertook clinical, neurophysiological and biochemica
195 xpression at the post-transcriptional level,
we undertook complementary computational, comparative ge
196 In this study,
we undertook comprehensive genetic and transgenic analys
197 We undertook country case studies in Papua New Guinea, U
198 In parallel,
we undertook detailed environmental testing for NTM and
199 Here,
we undertake epigenome imputation by leveraging such cor
200 identify novel MTC/CCH predisposition genes
we undertook exome resequencing studies in a family with
201 We undertook exome sequencing on lymphocyte DNA from fou
202 METHODS AND
We undertook four country case studies in Lesotho, Mozam
203 Between February, 2009, and January, 2013,
we undertook four proof-of-concept clinical trials in th
204 y systemic interleukin-1beta administration,
we undertake gene network analysis of the microglial tra
205 We undertook genome sequencing and annotation, gene expr
206 We undertook genome-wide analyses to identify DSX target
207 Here,
we undertook genome-wide analysis of camptothecin-treate
208 We undertook genome-wide association analysis of data co
209 ceptibility loci for visceral leishmaniasis,
we undertook genome-wide association studies in two popu
210 Here,
we undertook genome-wide profiling of cerebellar 5hmC in
211 underlying growth promotion by LRH-1 in CRC,
we undertook global expression profiling following siRNA
212 , peptides, protein partners, and chromatin,
we undertake here a configurational ensemble approach to
213 We undertook large-scale human genetic analyses to addre
214 We undertook logistic regression using data from the UK
215 We undertook meta-analyses to derive pooled estimates of
216 We undertook meta-analyses to derive pooled estimates of
217 We undertook meta-analyses whenever values of inflammato
218 We undertook model development with data from the Nation
219 We undertook morphological and functional studies to ass
220 We undertook multivariable linear regression to test eff
221 We undertook NMR-stratified multicentre, randomised, pla
222 We undertook parallel studies in endothelial cells deriv
223 Here,
we undertook phosphoproteomic analyses to identify and q
224 We undertook post-hoc analyses of mosquito catches made
225 ue to central nervous system inaccessibility
we undertook quantification of phosphatidylethanolamine
226 Herein,
we undertook quantum mechanical calculations of four mim
227 ical or radiographic records were preserved,
we undertook radiographic examination of the skeletons o
228 better characterize such intermediate steps,
we undertook rapid kinetic studies of the FRET and fluor
229 We undertook replicate phase 3 studies to assess the eff
230 We undertook Scotland-wide record linkage of education (
231 We undertook semi-structured interviews by telephone wit
232 ifferences among groups in assay approaches,
we undertook side-by-side testing of published methods o
233 We undertook simulations to reveal the conditions (i.e.
234 ences that could contribute to these traits,
we undertook SOLiD high-throughput sequencing of the roo
235 physicochemical properties of the chemotype,
we undertook structure based molecular design to identif
236 ntify novel dual TLR7/TLR8-active compounds,
we undertook structure-activity relationship studies in
237 ECAM-1-PECAM-1 homophilic-binding interface,
we undertook studies aimed at determining the crystal st
238 We undertook studies to examine how mGlu modulation affe
239 cular mechanism(s) of action of these drugs,
we undertook studies to identify amino acid residues in
240 n promotes Th2 immunity in viral infections,
we undertook studies to investigate whether LAPCs have a
241 the development of clinical recommendations,
we undertook systematic reviews to critically assess evi
242 Here
we undertake the first analysis of Caribbean spiny lobst
243 Here,
we undertake the first assessment of the potential ancil
244 Here
we undertake the largest canine genome-wide association
245 In this report,
we undertook the epidemiological and molecular character
246 We undertook the first comprehensive analysis on the tox
247 We undertook the first mechanistic study of the full cyc
248 We undertook the first population receptive field functi
249 Here,
we undertook the first prospective study of faciobrachia
250 We undertook the first randomized controlled trial of th
251 We undertook the first systematic review and meta-analys
252 We undertook the generation of Pf1 knockout mice to eluc
253 Blueprint Neurotherapeutics Network project
we undertook the in vitro exploration to identify novel
254 We undertook the largest genome-wide association study o
255 We undertook the largest genotype association study, to
256 We undertook the largest GWAS to date in individuals wit
257 We undertook the placebo-controlled, randomised, double-
258 We undertook the present studies to search for potential
259 We undertook the SearchLyte trial programme to examine t
260 to identify additional informative markers,
we undertook the sequencing and analysis of the mitogeno
261 We undertook the Simplified Antibiotic Therapy Trial (SA
262 eron may be a factor in poor T-cell priming,
we undertook therapeutic vaccination in two chronically
263 We undertook this 32-week, open-label, phase 3 non-infer
264 We undertook this 52 week, randomised, double-blind, act
265 We undertook this analysis of KRAS mutation in four tria
266 We undertook this multicentre, open-label, randomised co
267 We undertook this phase 3, double-blind, placebo-control
268 We undertook this pragmatic, open, randomised controlled
269 We undertook this prospective cohort study at 22 public
270 We undertook this prospective cohort study to determine
271 We undertook this randomised, double-blind, efficacy, im
272 We undertook this randomised, double-blind, placebo-cont
273 We undertook this randomised, double-blind, placebo-cont
274 We undertook this study at two hospitals in Zhejiang and
275 We undertook this study to analyze the "galectin signatu
276 We undertook this study to compare genomic alterations i
277 We undertook this study to determine the FEV1 rate decli
278 We undertook this study to determine whether the low-inc
279 We undertook this study to elucidate the function of the
280 We undertook this study to extend those findings.
281 We undertook this study to investigate the localisation
282 We undertook this study to test the hypothesis that incr
283 To address the growing Zika virus epidemic,
we undertook this study with two first, to develop a saf
284 We undertook three country case studies in Papua New Gui
285 es across field and greenhouse environments,
we undertook three independent experiments using the swi
286 l utility as an anticancer vaccine adjuvant,
we undertook to develop a synthetic route toward single-
287 n in the earlier neuroanatomical literature,
we undertook to examine them.
288 n the signaling adaptor p66Shc in CLL cells,
we undertook to identify unique phenotypic traits caused
289 Therefore,
we undertook,
to our knowledge, the broadest investigati
290 Therefore,
we undertook,
to the best of our knowledge, the first sy
291 , CDKN2A-B, IGF2BP2 and KCNQ1) are mediated,
we undertook transancestral fine-mapping in 22 086 cases
292 We undertook translatome analysis of CD8 T-cell activati
293 We undertook tumor typing to classify MMR defects to det
294 We undertook two public (hospitals) and private (pharmac
295 We undertook urinary drug tests and behavioural intervie
296 Here
we undertake whole-genome and transcriptome sequencing o
297 We undertook whole genome sequencing of E. faecalis asso
298 We undertook whole-genome sequencing (WGS) of 495 E. fae
299 We undertook within-family association analysis after im
300 Here,
we undertook year-round deployments of data loggers to t